Training Programs Effects on Strength and Balance in Older Adults

June 3, 2024 updated by: University of Padova

Effect of a 12-week Training Program With Unstable Devices on Strength and Dynamic Balance in Older Adults

Ageing involves several physiological changes such as loss of muscle mass, muscle strength, and alteration of balance control mechanisms. Consequently, there is an increased fall risk that can lead the older adult to a reduced self-sufficiency in daily living activities. Investigating the role of different physical activities to counteract the age-related declines deserves attention. The present study aimed to evaluate the effects of two trainings performed with and without unstable devices, on dynamic balance control and lower limb strength compared to a control group that received no intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The a-priori power analysis calculation reported a total sample size of 51 participants. We decided to increase the sample size of approximatively 20% hypothesizing an increment of drop-outs due to the not completely solved COVID-19 pandemic at the time of the study.

In this single-blinded randomized controlled study, both intervention groups received 24 training sessions of 45 minutes each, twice a week for 12 weeks.The two intervention groups and the control group were tested at the baseline (T0), after six weeks (T1), and after twelve weeks (T2).

Subjects of the intervention groups had to complete at least 21 out of 24 training sessions. Moreover, all subjects had to complete all the assessments. Otherwise, they were completely excluded from the data analysis.

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Padova, Italy, 35131
        • Nutrition and Exercise Lab, DSB, University of Padova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 85 years (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • self-sufficiency in daily living activities;
  • aged between 65 and 85 years.

Exclusion Criteria:

  • non-corrected sight disorders
  • neurological disorders
  • regular assumption of drugs that can interfere with normal cognitive functioning
  • pathologies that contraindicate physical activity practice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Unstable (UNST)
12-week training protocol with unstable devices, twice a week.
Strength and balance training using different destabilizing devices
Experimental: Stable (ST)
12-week training protocol with stable devices, twice a week
Strength and balance training over firm surfaces
No Intervention: Control (CTRL)
No administration of training protocols.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center of Pressure (CoP) Unit Path
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

From the center of pressure (CoP) trajectory the following parameter is calculated in the dynamic test:

- The mean velocity of the CoP measured in cm∙s-1 (Unit Path) over a 2.5-second time window from the beginning of the perturbation;

At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Center of Pressure (CoP) Area95
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

From the center of pressure (CoP) trajectory the following parameter is calculated in the dynamic test:

- The area of the 95th percentile confidence ellipse of the CoP measured in cm2 (Area95) over a 2.5-second time window from the beginning of the perturbation.

At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Center of Pressure (CoP) First Peak
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

From the center of pressure (CoP) trajectory the following parameter is calculated in the dynamic test:

- First peak (FP) as the difference in centimeters between the peak reached by the CoP displacement after the external perturbation and the mean value of the anterior-posterior CoP displacement before the perturbation.

At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Center of Pressure (CoP) Maximal Oscillation
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

From the center of pressure (CoP) trajectory the following parameter is calculated in the dynamic test:

- Maximal oscillation of the CoP anterior-posterior displacement as the sum in centimeters of the absolute values of FP and the subsequent peak.

At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Center of Pressure (CoP) Post Perturbation Variability
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

From the center of pressure (CoP) trajectory the following parameter is calculated in the dynamic test:

- The standard deviation (SD) of the CoP anterior-posterior displacement over a 2.5-second time window from the beginning of the perturbation as the post perturbation variability (PPV), measured in centimeters.

At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Lower limb isometric strength
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Isometric quadriceps maximal strength (Newton) measured with an instrumented chair. Specifically, a load cell is placed perpendicular to the subject's shank and collects the force in Newton expressed by the subject while sitting on the chair. The knee angle during the maximal effort is fixed at 90 degrees.
At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and Go (TUG) test
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Stand up from a chair, walk at the preferred pace to a cone at 3 meters, turn around, and walk back to the chair to sit down. The outcome is the time measured in seconds to complete the test.
At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
10-meter walking test
Time Frame: At baseline (t0), after six weeks (t1) and after 12 weeks (t2)
Walking 20 meters in a straight line at the preferred speed. The outcome is the time measured in seconds to complete the distance from the 5th to the 15th meter.
At baseline (t0), after six weeks (t1) and after 12 weeks (t2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2022

Primary Completion (Actual)

April 28, 2023

Study Completion (Actual)

April 28, 2023

Study Registration Dates

First Submitted

October 11, 2022

First Submitted That Met QC Criteria

March 13, 2023

First Posted (Actual)

March 15, 2023

Study Record Updates

Last Update Posted (Estimated)

June 4, 2024

Last Update Submitted That Met QC Criteria

June 3, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • UNST2223

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall

Subscribe